Dataset from A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008973
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin
degludec on blood sugar levels in participants with type 2 diabetes. The study will last
about 67 weeks and may include up to 22 visits.
创建时间：
2026-03-23
